Sektörün Lider Yayını… Haberde Tarafsız, Yorumda Özgürüz… Sektörün Lider Yayını… Haberde Tarafsız, Yorumda Özgürüz… Sektörün Lider Yayını… Haberde Tarafsız, Yorumda Özgürüz… Sektörün Lider Yayını… Haberde Tarafsız, Yorumda Özgürüz… Sektörün Lider Yayını… Haberde Tarafsız, Yorumda Özgürüz… Sektörün Lider Yayını… Haberde Tarafsız, Yorumda Özgürüz… Sektörün Lider Yayını… Haberde Tarafsız, Yorumda Özgürüz… Sektörün Lider Yayını… Haberde Tarafsız, Yorumda Özgürüz…
Gündemden Notlar
Sis Çanı
Ayak İzleri
Majistral Formül
Özgür Köşe
Kamu Kurum
Kültür Sanat
Ana Sayfa
Eczacı Odaları
Eczacı Kooperatifleri
Reçete Giriş
TV ler
Ana Sayfam Yap
Sık Kullanılanlara Ekle
Site İçi Arama
Üye Girişi



Sayın üyemiz,

  • "FORUM" sayfalarında yazılan yazılar, başka bir haber kaynağından kopyalanıp yapıştırılan koruma altında olan, kaynağı belirtilmeyen materyaller, yazıları yazan ve/veya materyalleri kopyalayıp yapıştıran kişinin/kişilerin yasal sorumluluğundadır.
  • Hakaret, argo, herhangi bir somut belgeye dayandırılmayan itham ve isnat, kişilik haklarına saldırı ve bir ürünün reklamını içeren, TC yasalarına ve meslek etiğine aykırı yazılar, yazarına haber verilmeksizin yayından kaldırılır.
  • Durum paylaşmak amacı ile yayınlanan reçete, rapor gibi materyallerde hasta ve doktora ait özel bilgilerin (isim, TC no, tescil no vb) gösterilmemesine özellikle dikkat edilmelidir.
  • "FORUM" sayfalarına vereceğiniz katkı ve anlayışınız için teşekkür ederiz.

Eczacının Sesi e-gazete Yayın Kurulu

UYARI: Forumda "Yeni Konu" açabilmek veya "Yanıt" yazabilmek için
üye olmanız gereklidir.

| Üye Girişi || Yeni Üye Kaydı || FORUM ARŞİVİ || YASAL UYARI |

adana dan 28-12-2009 15:49:04



19 May 2009

Judgements of the Court of Justice in Case C-531/06 and in Joined Cases C-171/07 and C-172/07

Commission v Italy

Apothekerkammer des Saarlandes and Others



Italian and German legislation laying down such a rule is justified by the objective of ensuring that the

provision of medicinal products to the public is reliable and of good quality.

Today, the Court of Justice has brought to a close two sets of proceedings relating to the system of

pharmacy ownership.

The cases relate, principally, to the issue whether Community law precludes provisions contained in

Italian and German legislation which provide that only pharmacists may own and operate a pharmacy.

Joined Cases C-171/07 and C-172/07 (Apothekerkammer des Saarlandes and Others) arose from the

authorisation granted by the competent ministry in Saarland to DocMorris, a Netherlands public

limited company, entitling it to operate a branch pharmacy in Saarbrücken from 1 July 2006. The

ministry’s decision was challenged before the Administrative Court, Saarland, by several pharmacists

and their professional associations, on the ground that it was not consistent with German legislation

which restricts the right to own and operate a pharmacy exclusively to pharmacists.

The Administrative Court referred questions to the Court of Justice in order to ascertain whether the

Treaty provisions on freedom of establishment must be interpreted as precluding such legislation.

In addition, in Case C-531/06 (Commission v Italy) the Commission applied to the Court for, amongst

others, a declaration that, by allowing only pharmacists to own and operate private pharmacies, the

Italian Republic has failed to fulfil its obligations under Community law.

In its judgments delivered today, the Court states that excluding the possibility for non-pharmacists to

operate pharmacies or to acquire stakes in companies or firms operating pharmacies constitutes a

restriction on the freedom of establishment and the free movement of capital.

That restriction can nevertheless be justified by the objective of ensuring that the provision of

medicinal products to the public is reliable and of good quality.

Where there is uncertainty as to the existence or extent of risks to human health, it is important that a

Member State should be able to take protective measures without having to wait until the reality of

those risks becomes fully apparent. Furthermore, a Member State may take the measures that reduce,

as far as possible, a public-health risk, including, more specifically, a risk to the reliability and quality

of the provision of medicinal products to the public.

In this context, the Court draws attention to the very particular nature of medicinal products, whose

therapeutic effects distinguish them substantially from other goods.

Those therapeutic effects have the consequence that, if medicinal products are consumed unnecessarily

or incorrectly, they may cause serious harm to health, without the patient being in a position to realise

that when they are administered.

Overconsumption or incorrect use of medicinal products leads, moreover, to a waste of financial

resources which is all the more damaging because the pharmaceutical sector generates considerable

costs and must satisfy increasing needs, while the financial resources which may be made available for

healthcare are not unlimited, whatever the mode of funding applied.

Given the power accorded to the Member States to determine the level of protection of public health,

Member States may require that medicinal products be supplied by pharmacists enjoying genuine

professional independence.

It is undeniable that a pharmacist, like other persons, pursues the objective of making a profit.

However, as a pharmacist by profession, he is presumed to operate the pharmacy not with a purely

economic objective, but also from a professional viewpoint. His private interest connected with the

making of a profit is thus tempered by his training, by his professional experience and by the

responsibility which he owes, given that any breach of the rules of law or professional conduct

undermines not only the value of his investment but also his own professional existence.

Unlike pharmacists, non-pharmacists by definition lack training, experience and responsibility

equivalent to those of pharmacists. Accordingly, they do not provide the same safeguards as


A Member State may therefore take the view, in the exercise of its discretion, that the operation of a

pharmacy by a non-pharmacist may represent a risk to public health, in particular to the reliability and

quality of the supply of medicinal products at retail level.

The Court also finds that it has not been established before it that a measure less restrictive than the

exclusion of non-pharmacists would make it possible to ensure just as effectively the level of

reliability and quality in the provision of medicinal products to the public that results from the

application of that exclusion.

Having regard to the discretion which it is allowed, a Member State may take the view that there is a

risk that less restrictive rules designed to ensure the professional independence of pharmacists, such as

a system of controls and penalties, would not be observed in practice, given that the interest of a nonpharmacist

in making a profit would not be tempered in a manner equivalent to that of self-employed

pharmacists and that the fact that pharmacists, when employees, work under an operator could make it

difficult for them to oppose instructions given by him.

The Court concludes that the freedom of establishment and the free movement of capital do not

preclude national legislation which prevents persons not having the status of pharmacist from owning

and operating pharmacies.

Since the Court finds that not only the exclusion of non-pharmacists from operation of a pharmacy can

be justified, but also the prohibition preventing undertakings engaged in the distribution of

pharmaceutical products from taking stakes in municipal pharmacies, it dismisses the action for failure

to fulfil obligations brought by the Commission against Italy.

Unofficial document for media use, not binding on the Court of Justice.

The full text of the judgments may be found on the Court’s internet site,

They can usually be consulted after midday (CET) on the day judgment is delivered.

For further information, please contact Christopher Fretwell

Tel: (00352) 4303 3355 Fax: (00352) 4303 2731

Pictures of the delivery of the judgments are available on EbS “Europe by Satellite”, a service

provided by the European Commission, Directorate-General Press and Communications,

L-2920 Luxembourg, Tel: (00352) 4301 35177 Fax: (00352) 4301 35249

or B-1049 Brussels, Tel: (0032) 2 2964106 Fax: (0032) 2 2965956

yüksel coşkun